Literature DB >> 16356300

Capecitabine/Oxaliplatin combinations in advanced colorectal cancer: summary of recent randomized studies.

G Kesava Reddy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356300     DOI: 10.1016/s1533-0028(11)70189-x

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  1 in total

1.  Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study.

Authors:  E Bajetta; M Di Bartolomeo; R Buzzoni; L Mariani; N Zilembo; E Ferrario; S Lo Vullo; E Aitini; L Isa; C Barone; S Jacobelli; E Recaldin; G Pinotti; A Iop
Journal:  Br J Cancer       Date:  2007-01-23       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.